QQ客服 官方微博 反馈留言

	Advances in inhibition of protein-protein interactions targeting hypoxia-inducible factor-1 for cancer therapy.
	Jia Li; Wanlin Xi; Xiaofang Li; Haiying Sun; Yuyan Li
刊名	Bioorganic & medicinal chemistry
	2019
关键词	Cancer therapy HIF-1 HIF-1α/HIF-1β hetero-dimerization HIF-1α/p300 PPIs Small molecular inhibitors
ISSN号	1464-3391
URL标识	查看原文
公开日期	[db:dc_date_available]
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4612154
专题	湖南大学
作者单位	Jiangsu Key Laboratory of Drug Design and Optimization, Department of Medicinal Chemistry, China Pharmaceutical University, Nanjing 210009, China. Jiangsu Key Laboratory of Drug Design and Optimization, Department of Medicinal Chemistry, China Pharmaceutical University, Nanjing 210009, China. Electronic address: haiyings1969@cpu.edu.cn. Jiangsu Key Laboratory of Drug Design and Optimization, Department of Medicinal Chemistry, China Pharmaceutical University, Nanjing 210009, China. Electronic address: yuyanli@cpu.edu.cn.
推荐引用方式 GB/T 7714	Jia Li,Wanlin Xi,Xiaofang Li,et al. Advances in inhibition of protein-protein interactions targeting hypoxia-inducible factor-1 for cancer therapy.[J]. Bioorganic & medicinal chemistry,2019.
APA	Jia Li,Wanlin Xi,Xiaofang Li,Haiying Sun,&Yuyan Li.(2019).Advances in inhibition of protein-protein interactions targeting hypoxia-inducible factor-1 for cancer therapy..Bioorganic & medicinal chemistry.
MLA	Jia Li,et al."Advances in inhibition of protein-protein interactions targeting hypoxia-inducible factor-1 for cancer therapy.".Bioorganic & medicinal chemistry (2019).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。